ALPHAEON announces acquisition of Rocol SA

NewsGuard 100/100 Score

ALPHAEON Corporation, a social commerce company and subsidiary to Strathspey Crown Holdings LLC, today announced its acquisition of Rocol SA, a leader in the commercialization of medical equipment across Latin America. Terms of the acquisition were not disclosed.

Headquartered in Barranquilla, Colombia, Rocol provides products, services, and medical equipment in the fields of ophthalmology, dermatology, aesthetics, oncology and robotics for the entire Latin American market.

"Rocol is a well-respected and recognized leader in the commercialization of medical equipment in ophthalmology and aesthetics across Latin America," said Robert E. Grant, CEO of ALPHAEON. "This acquisition enables ALPHAEON to expand its presence in these key emerging markets."

"We believe ALPHAEON's social commerce platform, practice management suite and broad product portfolio will allow us to offer greater value to our customers," said Roberto Garcia, President of Rocol. "Together we believe we have a tremendous opportunity to drive the business forward utilizing ALPHAEON's digital platform and our market expertise."

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Advances and hurdles: The impact of AI on oncology care efficiency and mortality rates